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Abstract
Background: The incidence and risk factors of methicillin-resistant Staphylococcus aureus (MRSA)
acquisition after living donor liver transplantation (LDLT) are unclear. The aim of the present study
was to assess the incidence and to analyze the risk factors for the acquisition of MRSA after LDLT
in adults by multivariate analysis.
Methods: We retrospectively reviewed the data from 158 adult patients that underwent LDLT at
the Tokyo University Hospital. The microbiologic and medical records of the patients from
admission to 3 months after LDLT were reviewed. Uni- and multivariate analyses were performed
to identify the risk factors for postoperative acquisition of MRSA.
Results:  Postoperative MRSA acquisition was detected in 35 of 158 patients by median
postoperative day 18. Age (>= 60 y) and perioperative dialysis and/or apheresis predicted
postoperative MRSA acquisition by multivariate analysis. In contrast, postoperative use of
fluoroquinolone was negatively associated with acquisition of MRSA.
Conclusion: MRSA arose early after LDLT in adults with a high incidence (35 of 158 patients).
Surveillance culture should be checked periodically after LDLT to identify and prevent the
transmission of MRSA.
Background
Methicillin-resistant Staphylococcus aureus (MRSA) infec-
tion frequently complicates the postoperative course of
deceased donor liver transplantation (DDLT) recipients
[1-5]. In some centers, 91% (45 of 49 isolates) of all Sta-
phylococcus aureus infections after DDLT are caused by
MRSA [2].
Preoperative MRSA carriage is associated with an
increased risk of MRSA infection after DDLT [1,3-5]. Pos-
itive MRSA culture in postoperative as well as in preoper-
ative surveillance is important because the finding of
MRSA colonization in a patient during hospitalization
increases the risk of MRSA infection [6]. In one prospec-
tive study [6], the relative risk for developing MRSA infec-
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tion in patients who had MRSA colonization was higher
than that in patients who were not colonized with Staphy-
lococcus aureus. In this particular study, 12 of 394 patients
had MRSA colonization during hospitalization, and 4 of
12 (25%) later developed MRSA infection.
Few studies have focused on the factors associated with
the acquisition of MRSA following liver transplantation.
In one prospective study [7], the use of a urinary catheter
for a prolonged period, postoperative bleeding at the sur-
gical site, and preoperative use of fluoroquinolones inde-
pendently increased the risk of MRSA colonization after
DDLT. MRSA in cases of living donor liver transplantation
(LDLT), in which operations are performed in a more
scheduled manner, is not well documented.
The aim of the present study was to study the factors asso-
ciated with the acquisition of MRSA after LDLT in adults
assessed by surveillance cultures obtained from multiple
sites, including nares, and to analyze the risk factors by
multivariate analysis.
Methods
Patients
We retrospectively reviewed the data from 171 patients
that underwent LDLT at the University of Tokyo Hospital,
a 1150-bed teaching hospital, between August 2001 and
November 2004. Of 171 patients, 13 were colonized with
MRSA preoperatively and were excluded from the study.
The median patient age was 51 years (range, 19–67). The
indications for LDLT in these patients included hepatitis C
(n = 53), hepatitis B (n = 24), primary biliary cirrhosis (n
= 24), fulminant hepatitis (n = 18), biliary atresia (n = 8),
autoimmune hepatitis (n = 7), primary sclerosing cholan-
gitis (n = 5), metabolic disease (n = 5), alcoholic cirrhosis
(n = 4), cryptogenic cirrhosis (n = 2), and others (n = 8).
Of the 158 patients, 68 had hepatocellular carcinoma. The
median Child-Pugh score and model for end stage liver
diseases (MELD) score of those patients was 10 (range, 5–
14) and 13 (range, -3 to 48), respectively. The microbio-
logic and medical records of the patients from admission
to 3 months after LDLT were reviewed. The present study
was approved by The University of Tokyo Ethical Com-
mittee. The data used for the study are publicly available.
Donor selection
Donors were selected from the patients' relatives. Age,
blood type, graft size, and liver function were also taken
into consideration. ABO blood groups were required to be
identical to or compatible with that of the recipients. The
graft type was determined according to the ratio of the
estimated graft volume to the recipient's standard liver
volume ratio [8,9]. Our surgical technique for recipient
and donor surgery is described elsewhere [10]. Donors
were not routinely screened for Staphylococcus aureus peri-
operatively.
Perioperative management
Antimicrobial prophylaxis consisted of intravenous cefo-
taxime (1.0 g just before surgery, followed by 1.0 g every
6 hours intraoperatively and thereafter), ampicillin/sul-
bactam (1.0 g just before surgery, followed by 1.5 g every
12 hours intraoperatively and thereafter), and gentamicin,
60 mg every 12 hours after surgery) for 5 days.
To prevent fungal infection, fluconazole (200 mg every 24
hours) was administered intravenously for 7 days after
surgery. All patients received the same immunosuppres-
sive regimens using tacrolimus (Prograf, Astellas Pharma-
ceutical Corporation, Tokyo, Japan) and
methylprednisolone (Solu-Medrol, Pfizer Inc., New York,
NY). The details of the regimen are reported elsewhere
[11].
Definition of MRSA colonization
All the patients were screened preoperatively for Staphylo-
coccus aureus on admission for LDLT. Follow-up speci-
mens were collected twice a week during the first month
after LDLT, and thereafter once a week during the hospital
stay. Routine surveillance specimens consisted of swabs of
the anterior nares, pharynx, sputum, urine, and stool. In
addition, swabs of wound or skin lesions, bile, and dis-
charge from the abdominal cavity were collected postop-
eratively. Blood samples, collected percutaneously, and a
segment of a removed intra-vascular catheter were also
submitted when infection was suspected as the follow-
ings: fever (> 38°C), chills, or hypotension. Other clinical
samples were added in patients with suspected infection
according to the discretion of the attending physician.
Specimens were plated onto mannitol-salt agar or sheep
blood agar. Staphylococcus aureus was identified using
standard microbiologic methods.
Methicillin resistance was determined using a disk diffu-
sion test performed on Mueller-Hinton agar after incuba-
tion for 24 to 48 hours at 30°C. By the microdilution
method, strains with an oxacillin minimum inhibitory
concentration value of at least 4 μg/ml were defined as
MRSA [12]. Patients colonized with Staphylococcus aureus
at any site, and at any time during the hospital stay, were
considered carriers.
Definition of MRSA infection
Nosocomial infections were defined according to the
reports from the Centers for Disease Control and Preven-
tion in 1988 and in 1992, as described elsewhere [13,14].
When MRSA was isolated from culture samples in theBMC Infectious Diseases 2008, 8:155 http://www.biomedcentral.com/1471-2334/8/155
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presence of nosocomial infection and other pathogenic
organisms were absent, MRSA infection was diagnosed.
Management of precaution for transmission of MRSA
0.2% benzalkonium chloride ethanol solution (Welpas,
Maruishi Pharmaceutical Corporation, Oosaka, Japan)
were used for hand hygiene of patients, medical, and non-
medical staffs in contact with patients. Contact precau-
tions were taken in cases with MRSA colonization and/or
infection. Eradication therapy such as intranasal mupi-
rocin was not routinely performed. The screening of med-
ical staffs for detection of MRSA was not also performed
during the study period.
Background and clinical data collection
Background and clinical data collected for each patient
included:
1) preoperative variables (age, gender, etiology of the
underlying liver disease, presence of hepatocellular carci-
noma, Child-Pugh score, MELD score, presence of ascites,
use of diuretics, presence of encephalopathy, the interna-
tional normalized ratio of prothrombin time level, serum
bilirubin level [mg/dl], serum albumin level [g/dl], serum
creatinine level [mg/dl], use of steroid, use of antimicrobi-
als during the month before LDLT, presence of diabetes
mellitus, history of hospital stay during the 6 months
before LDLT, and methicillin-susceptible Staphylococcus
aureus colonization;
2) surgical variables (operation time [hours], estimated
blood loss [ml], blood transfusion [ml], graft volume/
standard liver volume ratio [%], and application of duct
to duct biliary reconstruction;
3) postoperative variables (length of urinary catheter
insertion [days], length of arterial catheter insertion
[days], length of central venous catheter insertion [days],
length of endotracheal tube insertion [days], necessity for
reoperation, acute rejection, cytomegalovirus infection,
fungal infection, and postoperative use of antimicrobials
other than the routine perioperative prophylaxis); and
4) pre- and postoperative variables (length of intensive
care unit stay [days], and application of dialysis and/or
apheresis).
Statistical analysis
Quantitative variables are presented as median and range.
Categorical variables are presented as absolute counts.
Univariate analysis was used to identify associations
between each of the variables recorded and postoperative
acquisition of MRSA. Wilcoxon rank sum test was used to
compare the quantitative variables. Chi-square test or
Fisher's exact test was used to compare the categorical
data.
For multivariate analysis, only variables with a p value of
less than 0.25 in the univariate analysis were entered into
a logistic regression model by the backward-elimination
procedure. The final regression model included covariates
associated with a likelihood ratio of p less than 0.15. The
results of the logistic regression were reported as odds
ratios with 95% confidence intervals. A p value of less
than 0.05 was considered statistically significant. All sta-
tistical analyses were performed using the JMP5.1 soft-
ware package (SAS Institute Inc., Cary, NC).
Results
Acquisition of MRSA after LDLT
The median number of screening samples for each patient
and the compliances with surveillance culture for nares,
pharynx, sputum, urine, and stool were 9 (range, 1–25), 9
(range, 0–25), 5 (range, 0–25), 9 (range, 1–24), and 6
(range, 0–22) samples, and 82%, 82%, 50%, 80%, and
60%, respectively. Data on the detection of postoperative
acquisition of MRSA are summarized in Figure 1. Postop-
erative acquisition of MRSA was detected in 35 of 158
patients (22%) during the study period. The median
period of time between LDLT and detection of MRSA was
postoperative day 18 (range, 1–89 days). In 8 of 35
patients, MRSA was detected during the intensive care unit
stay. Median length of hospital stay after LDLT were 45
(range, 6–90) days in patients without MRSA acquisition
and 59 (range, 33–90) in those with MRSA acquisition,
respectively (p = 0.0006). Eleven of 158 (7%) patients
developed MRSA infection during the study period: deep
incisional surgical site infection (SSI) in 5, organ/space
SSI in 2, intraabdominal infection in 2, lower respiratory
infection in 1, and primary bloodstream infection in 1
patient, respectively. MRSA infections were eventually
The patient profile of postoperative MRSA colonization and  infection Abbreviations: MRSA, methicillin-resistant Staphylo- coccus aureus; LDLT, living donor liver transplantation Figure 1
The patient profile of postoperative MRSA coloniza-
tion and infection Abbreviations: MRSA, methicillin-
resistant Staphylococcus aureus; LDLT, living donor 
liver transplantation.BMC Infectious Diseases 2008, 8:155 http://www.biomedcentral.com/1471-2334/8/155
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diagnosed in 7 of 31 patients (23%) who were colonized
with MRSA while only 4 of 127 subjects (3%) with nega-
tive surveillance cultures developed MRSA infection (p =
0.01). Table 1 shows the frequency of detection of MRSA
from different clinical and surveillance specimens. In 30
subjects (86%) MRSA was isolated in more than 2 sites.
Risk factors for the Acquisition of MRSA after LDLT
The results of the univariate analyses assessing the associ-
ation between the acquisition of MRSA and clinical cov-
ariates are shown in an additional file 1. Age of at least 60
years (p = 0.01), presence of an endotracheal tube for at
least 3 days (p = 0.03), and perioperative dialysis and/or
apheresis (p = 0.008) were significant factors affecting the
acquisition of MRSA. In the multivariate analyses (Table
2), 10 risk factors with a univariate p value of less than
0.25 were entered into a logistic regression model by the
backward-elimination procedure. In the final model, age
of at least 60 years and perioperative dialysis and/or
apheresis predicted the postoperative acquisition of
MRSA. In contrast, postoperative use of fluoroquinolone
was negatively associated with acquisition of MRSA.
Discussion
To date, this is the largest series study of the presence of
MRSA after LDLT in adults. Of 158 patients, 35 (22%) pre-
sented a positive culture for MRSA by median postopera-
tive day 18. The rate in the present study was higher than
that in the recently published prospective study in DDLT
[7], in which 9 of 60 (15%) patients acquired nasal MRSA
colonization by median postoperative day 24. Patients
who acquired MRSA were significantly associated with an
increased length of hospital stay in the present study. Sim-
ilary, Singh et al. reported that an increased length of hos-
pital stay was associated with new Staphylococcus aureus
carriage acquisition in DDLT[15]. Longer hospital stay,
which is one of a marker for greater severity of illness, also
might have identified high risk candidates requiring more
intensive care, which could lead an increasing chance of
MRSA transmission. Although the anterior nares is the
most frequent carriage site for Staphylococcus aureus [16],
other extra-nasal sites such as skin, perineum, pharynx,
gastrointestinal tract, vagina, and axillae can harbor the
organism [5,16]. MRSA from the nares was detected in 24
of 158 (15%) patients in the present study, which was
comparable to the result of the previous report [7]. Of the
31 patients with MRSA-positive cultures, 7 (23%) subse-
quently developed MRSA infection. In addition, 7 of 11
(64%) patients who developed MRSA infection were col-
onized with MRSA prior to infection while only 4 of the
127 subjects (3%) with negative surveillance cultures
developed MRSA infection (p = 0.001). This is in line with
the findings of other authors, which indicated that inter-
ventions aimed at curtailing the transmission of MRSA
may have a beneficial impact on the incidence of MRSA
infection [17,18]. Furthermore, this is useful information
in that it allows for earlier administration of a more
appropriate antibiotic such as vancomycin in patients sus-
pected of having MRSA infection.
The present study indicated that age of at least 60 years
increased the risk of postoperative acquisition of MRSA by
multivariate analysis. As a large number of variables (N =
39) were included in the analyses in the present study, we
must recognize the possibility that statistical association
might have occurred by chance. The exact reason why
older patients acquire MRSA more frequently after LDLT is
unclear. Some previous studies [19,20] reported that older
age was a risk factor for MRSA acquisition during hospital-
ization, although the interpretation was not described.
Another risk factor indicated by the present study, dialysis
and/or apheresis, requires indwelling devices such as
intravascular catheters. Invasive procedures are "entrance
gates" for microorganisms, and potential hand contami-
nation of personnel who perform these procedures might
increase the risk of MRSA transmission [19]. On the other
hand, perioperative dialysis and/or apheresis might
merely be suggestive of the intensity of care required for
patients in the present study. Perioperative dialysis and/or
apheresis, mostly indicated in cases of deteriorated liver
dysfunction in the present study, might suggest the deteri-
orated general conditions of patients, making them more
prone to infectious diseases. Intensity of care required can
be considered a surrogate marker for a number of manip-
ulations that are major risk factors for MRSA transmission
[21].
It might be better to adopt additional strategies for
patients with these risk factors of MRSA acquisition. Singh
et al. [15] reported an impact of an aggressive infection
control strategy on Staphylococcus aureus infection in liver
transplant recipients, including use of surveillance cul-
Table 1: Frequency of MRSA detection in different surveillance 
and clinical specimens of 35 patients
Sites Number of patients (%)
Nares 24 (69%)
Pharynx 21 (60%)
Sputum 18 (51%)
Stool 18 (51%)
Urine 11 (31%)
Wound 8 (23%)
Intraabdominal drain 5 (14%)
Bile 3 (9%)
Intravascular catheter 2 (6%)
Ascites 2 (6%)
Pleural effusion 2 (6%)
Blood 1 (3%)
Thirty of 35 patients had MRSA detected from multiple sites.BMC Infectious Diseases 2008, 8:155 http://www.biomedcentral.com/1471-2334/8/155
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tures to detect nasal and rectal colonization, use of cohort
and contact isolation precautions, decolonization with
intranasal mupirocin therapy, and educating patients and
visitors about hand hygiene and MRSA transmission. In
that study, the rate of new acquisition of Staphylococcus
aureus decreased from 46% during the pre-intervention
period to 10% during the post-intervention period, and
the rate of Staphylococcus aureus infection decreased from
40% to 4%, respectively.
The intensity of the use of antimicrobials, measured by
the presence of preoperative antibiotic use during the
month before LDLT did not correlate with the acquisition
of MRSA after transplantation in the present study. Fur-
thermore, postoperative use of fluoroquinolone was neg-
atively associated with acquisition of MRSA, which was
contrary to our expectations. It was difficult to analyze
whether the postoperative frequency of use of antimicro-
bials increased a risk of MRSA acquisition in the present
study. Only the antimicrobials used before the first date of
detection of MRSA were included in the analysis, which
caused the difference of observation period for exposure
to antimicrobials between patients with and without
acquisition of MRSA. The median period of time between
LDLT and detection of MRSA was postoperative day 18,
and 17 of 35 (49%) patients acquired MRSA within 2
weeks after the operation. Although there is little doubt
that widespread use of antimicrobials provides multidrug-
resistant strains of MRSA with a selective survival advan-
tage [22], the relation between MRSA and antimicrobials
seems more complex in the current series. Some studies
[23-29] failed to show such an association by multivariate
analysis. In other studies [30-33], exposure to specific
antimicrobials, such as third generation cephalosporins,
amoxicillin with clavulanic acid, quinolones, and other
broad-spectrum antibiotics, increased the risk of MRSA
infection or colonization. Crowcroft et al. [33] found no
association between total antimicrobial use and MRSA
colonization or infection and suggested that the problem
was the inappropriate use of antimicrobials, not excessive
use. This discrepancy is probably due to the fact that in the
present study all the patients received long courses of mul-
tiple antimicrobials resulting in broad coverage, as peri-
operative prophylaxis per protocol, and it is therefore
difficult to detect the effect of a specific antimicrobial. It
might also be better for reducing the acquisition of MRSA
to shorten prophylactic use of antimicrobials to a maxi-
mum of 48 hours as used in other transplant centers
[7,34].
One limitation of the present study is that the MRSA car-
riage pattern was not analyzed. Longitudinal studies have
distinguished three Staphylococcus aureus carriage patterns
in healthy individuals [15,35]. This distinction is impor-
tant because persistent carriers have higher Staphylococcus
aureus loads and a higher risk of acquiring Staphylococcus
aureus infection [36].
Another limitation of the present study is that we could
not differentiate the specific MRSA strains. Pulsed-field gel
electrophoresis analysis was not accessible and the data
were not obtained. Therefore, we could not analyze the
impact of MRSA transmission, such as patient-to-patient
transmission by transient carriage on the hands of the
medical staff in detail. Our observation remains specula-
tive on this point. Similarly, it was impossible to know
whether infection was due to the same strain as that of the
colonization or to a newly acquired strain. Chang et al. [4]
analyzed the isolates from infected sites and from the
anterior nares in seven patients with MRSA infection, and
reported that the same isolates were detected. Such
detailed analyses might yield further information to pre-
vent the spread of MRSA following LDLT.
Conclusion
There is a high incidence of MRSA early after LDLT in
adults. Surveillance cultures should be performed period-
ically after LDLT to identify and prevent the transmission
of MRSA.
Abbreviations
LDLT: living donor liver transplantation; DDLT: deceased
donor liver transplantation; MELD: model for end stage
liver diseases; MRSA: methicillin-resistant Staphylococcus
Table 2: Multivariate analysis of risk factors for the acquisition of MRSA after LDLT
Variable Odds Ratio
(95% Confidence interval)
p Value
Age >= 60 3.33(1.17–9.58) 0.03
Duct to duct biliary reconstruction 3.18(0.92–15.22) 0.07
Endotracheal tube (day) >= 3 2.26(0.87–5.84) 0.09
Postoperative use of beta lactam 0.49(0.20–1.23) 0.13
Postoperative use of fluroquinolone 0.14(0.007–0.88) 0.03
Perioperative dialysis and/or apheresis 2.92(1.16–7.39) 0.02
Abbreviations: MRSA, methicillin-resistant Staphylococcus aureus; LDLT, living donor liver transplantation.BMC Infectious Diseases 2008, 8:155 http://www.biomedcentral.com/1471-2334/8/155
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aureus; MSSA: methicillin-susceptible Staphylococcus
aureus.
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